Piramal Pharma Limited Atorvastatin Export Data — India (DGFT 2022–2026)

Name: Piramal Pharma Limited Atorvastatin Export Records India — #2 Exporter, 429 Shipments, $21.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Atorvastatin

India Pharmaceutical Trade Intelligence

$1.1B477 Suppliers145 CountriesHS 30049099

ExportsIndia → UNITED STATES52.5%India → CANADA25.9%

ImportsCROATIA → India$3.5M CANADA → India$2.5M

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: APOTEX CORP

Piramal Pharma Limited — Atorvastatin Exporter #2 | $21.4M Trade Value | TransData Nexus | TransData Nexus

Piramal Pharma Limited — Atorvastatin Exporter Profile

Indian Pharmaceutical Exporter · #2 for Atorvastatin · $21.4M export value · DGFT Verified

Piramal Pharma Limited is the #2 Indian exporter of Atorvastatin with $21.4M in export value and 429 verified shipments. Piramal Pharma Limited holds a 2.0% market share in Atorvastatin exports across 1 countries. The company exports 8 pharmaceutical products worth $64.5M across 5 therapeutic categories.

Piramal Pharma Limited — Atorvastatin Export Profile: Buyers & Destinations

Piramal Pharma Limited Atorvastatin export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Atorvastatin?

Country	Value	Shipments	Share
UNITED STATES	$194.4M	3,889	50.4%
MALTA	$32.5M	1,226	8.4%
UNITED KINGDOM	$30.2M	1,243	7.8%
CANADA	$29.4M	587

Who Are the Top Buyers of Atorvastatin from India?

Buyer	Country	Value	Orders
APL SWIFT SERVICES (MALTA) LTD.,	MALTA	$25.9M	517
APOTEX CORP	UNITED STATES	$21.4M	429
NOVADOZ PHARMACEUTICALS LLC	UNITED STATES	$17.3M	549
BIOCON PHARMA INC	UNITED STATES	$16.0M	339
YUSEN LOGISTICS BENELUX BELGIUM	BELGIUM	$14.7M	663
LIFESCIENCE LOGISTICS	UNITED STATES	$6.7M	133
MYLAN PHARMACEUTICALS INC,	UNITED STATES	$5.0M	99
ACCORD HEALTHCARE INC.,	CANADA	$850.0K	17
BIOMEDPHARMA	CANADA	$800.0K	16
ASCEND LABOATORIES,LLC C/O UPS	UNITED STATES	$150.0K	3

India's Atorvastatin is purchased by 1,291 buyers worldwide. The top buyer is APL SWIFT SERVICES (MALTA) LTD., (MALTA), followed by APOTEX CORP and NOVADOZ PHARMACEUTICALS LLC.

How Does Piramal Pharma Limited Compare to Nearest Atorvastatin Exporters?

Exporters ranked immediately above and below #2 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
8	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$32.8M	1,299	18	$25.3K
9	GRAVITI PHARMACEUTICALS PRIVATE LIMITED	$24.0M	664	1	$36.1K
2	PIRAMAL PHARMA LIMITED ★	$21.4M	429	1	$50.0K
3	MYLAN LABORATORIES LIMITED	$16.5M	330	7	$50.0K
1	INTAS PHARMACEUTICALS LIMITED	$16.4M	328	10	$50.0K

Piramal Pharma Limited ranks #2 among 477 Indian Atorvastatin exporters. Average shipment value of $50.0K compared to the market average of $657.7K. The closest competitors by value are SUN PHARMACEUTICAL INDUSTRIES LIMITED and GRAVITI PHARMACEUTICALS PRIVATE LIMITED.

Which Indian Ports Ship Atorvastatin Exports?

Port	Shipments	% Share
HYDERABAD ICD	2,042	13.6%
HYDERABAD ICD (INSNF6)	1,131	7.5%
NHAVA SHEVA SEA (INNSA1)	842	5.6%
SAHAR AIR	839	5.6%
JNPT/ NHAVA SHEVA SEA	779	5.2%
DELHI AIR	613	4.1%
SAHAR AIR CARGO ACC (INBOM4)	581	3.9%
HYDERABAD AIR	554	3.7%

Geopolitical & Trade Policy Impact on Piramal Pharma Limited's Atorvastatin Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like PPL. The Israel-Iran tensions have led to increased security risks in the Red Sea, prompting major shipping lines to impose 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU. This escalation in shipping costs directly impacts the profitability of exports to Europe and the U.S. East Coast, necessitating strategic adjustments in logistics and pricing strategies. (sgexports.odoo.com)

Simultaneously, the 2025 United States–India diplomatic and trade crisis has introduced additional complexities. The U.S. administration's imposition of a 50% tariff on Indian exports, in response to India's energy policies, has significantly affected trade dynamics. This development compels companies like PPL to reassess their market strategies and explore alternative markets to mitigate the impact of these tariffs. (en.wikipedia.org)

On a positive note, the European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) has prompted the Directorate General of Foreign Trade (DGFT) in India to establish a 'CBAM Facilitation Cell.' This initiative aims to assist exporters in complying with new environmental regulations, potentially providing PPL with a competitive edge in the EU market by aligning with sustainability standards. (sgexports.odoo.com)

Piramal Pharma Limited — Regulatory Compliance & Quality Standards

Maintaining stringent quality standards is paramount for pharmaceutical exporters. PPL's Turbhe facility in Maharashtra underwent a U.S. FDA inspection in February 2025, resulting in a Form 483 with six observations. The company addressed these concerns, leading to the issuance of an Establishment Inspection Report (EIR) with a classification of Voluntary Action Indicated (VAI) in May 2025, signifying successful closure of the inspection. (business-standard.com)

Similarly, the Riverview facility in the U.S. received an EIR in April 2024, following a pre-approval inspection that concluded with three observations classified under VAI. These developments reflect PPL's proactive approach to regulatory compliance and its commitment to upholding global quality standards. (business-standard.com)

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Atorvastatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Piramal Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 145+ countries, 1,291+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Atorvastatin

Atorvastatin

Piramal Pharma Limited — Atorvastatin Exporter Profile

Piramal Pharma Limited — Atorvastatin Export Profile: Buyers & Destinations

Where Does India Export Atorvastatin?

Who Are the Top Buyers of Atorvastatin from India?

What Is India's Total Atorvastatin Export Value and How Much Does Piramal Pharma Limited Contribute?

What Is the Average Shipment Value for Piramal Pharma Limited's Atorvastatin Exports?

How Does Piramal Pharma Limited Compare to Other Indian Atorvastatin Exporters?

Regulatory Requirements: Exporting Atorvastatin to Key Markets

United States — FDA

United Kingdom — MHRA

How Does Piramal Pharma Limited Compare to Nearest Atorvastatin Exporters?

Which Indian Ports Ship Atorvastatin Exports?

What Other Cardiovascular Products Does Piramal Pharma Limited Export?

Geopolitical & Trade Policy Impact on Piramal Pharma Limited's Atorvastatin Exports

Piramal Pharma Limited — Regulatory Compliance & Quality Standards

About Piramal Pharma Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Atorvastatin Export Data from Piramal Pharma Limited

Atorvastatin Stats

Company Overview

Top Products by Piramal Pharma Limited

Related Analysis

Need Detailed Export Data?

Data Source